MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Sympathetic Nervous System Overactivity in the Pre-Motor Stage of Parkinson’s Disease: Therapeutic Implications

    M. Tagliati, M. Gregorio, H. Maghzi, G. Obialisi, E. Hogg, C. Malatt, E. Tan, M. Kelly, H. Pomeroy, R. Artal, M. Shehata, B. Renner, Z. Fan, P. Sati, G. Pagano (Los Angeles, USA)

    Objective: To investigate sympathetic nervous system (SNS) activity in idiopathic REM behavior disorder (iRBD) subjects at risk for Parkinson's disease (PD), and the effect of…
  • 2024 International Congress

    eHealth Technologies for People with Parkinson’s: Acceptance & Implications

    J. Stuempel, V. Fleckenstein, J. Hohn, K. Steidel, C. Münte, D. Pedrosa (Marburg, Germany)

    Objective: To investigate the impact of eHealth on Parkinson's care, focusing on technology acceptance and examining ethical, legal, social, and medical aspects of wearables. Background:…
  • 2024 International Congress

    Predictors of Death within 6 Months in Individuals with Dementia with Lewy Bodies

    M. Armstrong, Y. Dai, B. Labarre, H. Fechtel, K. Sovich, J. Galvin, H. Paulson, S. Maixner, C. Manning, J. Fields, A. Lunde, B. Boeve, L. Forsberg, A. Taylor, Z. Li (Gainesville, USA)

    Objective: To assess predictors of death in the subsequent 6 months in dementia with Lewy bodies (DLB). Background: Individuals with DLB commonly die of disease-related…
  • 2024 International Congress

    ORION: A Global Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial of AMX0035 in Progressive Supranuclear Palsy (A35-009)

    A-M. Wills, G. Höglinger, L. Mehta, M. Leinders, Y. Wu, J. Timmons, A. Hayden, I. Aiba, A. Antonini, A. Boxer, Y. Compta, J-C. Corvol, A. Lang, H. Morris, P. Svenningsson, H. [email protected], L. Golbe (Boston, USA)

    Objective: Here we describe ORION, a phase 3 trial assessing efficacy and safety of AMX0035 in progressive supranuclear palsy (PSP). Background: PSP is a rare,…
  • 2024 International Congress

    Noradrenaline treatment of apathy and impulsivity in participants with Progressive Supranuclear Palsy syndromes (NORAPS). A Phase II clinical trial – ISRCTN99462035.

    R. Durcan, J. Rowe (Cambridge, United Kingdom)

    Objective: The NORAPS Phase II clinical trial seeks to demonstrate safety, tolerability and efficacy of atomoxetine in Progressive Supranuclear Palsy (PSP). Background: PSP is a…
  • 2024 International Congress

    The Impact of Deep Brain Stimulation on the Embarrassment and Self-Esteem of Patients with Essential Tremor

    A. Dave, J. Frey, J. Yu, J. Lopes, C. Hess (Plainsboro, USA)

    Objective: To examine how Deep Brain Stimulation (DBS) influences embarrassment and self-esteem in patients with essential tremor (ET) and assess caregiver impressions. Background: Social embarrassment…
  • 2024 International Congress

    PreActive-PD Telehealth Coaching to Increase Physical Activity in Early-Stage Parkinson Disease: A Randomized Controlled Feasibility Trial

    K. Long, A. Pacheco, L. Quinn, D. Wani, J. Alomar, D. Kipnis, C. Macpherson (Walnut Creek, USA)

    Objective: To assess the feasibility/acceptability, and preliminary efficacy of Pre-Active PD intervention delivered via telehealth to increase physical activity (PA) engagement in people with early-stage…
  • 2024 International Congress

    The Prospect of Exoskeletons for Individuals with Parkinson’s Disease: A Comprehensive Review

    MYA. Amine, G. Bekheet, M. Sadek, S. Kastantin (Giza, Egypt)

    Objective: This comprehensive review provides a thorough analysis of the effects of robotic-assisted gait training on Parkinson's disease patients' gait parameters and makes recommendations for…
  • 2024 International Congress

    A telehealth physical activity coaching program can maintain physical activity and exercise confidence in people with Parkison disease: a cohort study.

    D. Wani, A. Chandrana, A. Pacheco, D. Kipnis, J. Alomar, C. Macpherson, J. Fineman, L. Quinn (New York, USA)

    Objective: To examine the efficacy of the Engage-PD program in sustaining physical activity gains in people with Parkison disease. Background: Parkinson disease (PD) is a…
  • 2024 International Congress

    Utility of Instrumented Timed Up and Go Test to Estimate Disease Severity in Huntington Disease.

    D. Wani, M. Lin, C. Macpherson, T. Ravikumar, M. Campbell, L. Muratori, N. Fritz, L. Quinn (New York, USA)

    Objective: To investigate the utility of Instrumented Timed Up and Go (TUG) test to estimate disease severity in people with Huntington Disease (PwHD). Background: Huntington…
  • « Previous Page
  • 1
  • …
  • 310
  • 311
  • 312
  • 313
  • 314
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley